Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment

Worapol Ngamcherdtrakul, David J. Castro, Shenda Gu, Jingga Morry, Moataz Reda, Joe W. Gray, Wassana Yantasee

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations

Fingerprint Dive into the research topics of 'Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences